Subdominance in Antibody Responses: Implications for Vaccine Development

Area of Science:

• Immunology
• Vaccinology
• Microbial Pathogenesis

Background:

• Traditional vaccine development focuses on eliciting antibodies against dominant antigens, but faces significant challenges.
• Recovery from natural infections often relies on cellular immunity, not solely antibody responses.
• Many pathogens lack effective vaccines due to difficulties in identifying protective antigens.

Purpose of the Study:

• To review evidence supporting the significance of subdominant protein regions in vaccine development.
• To explore the concept of subdominance as a potential immune evasion mechanism and key target for protective immunity.
• To discuss the implications of subdominant regions for designing vaccines against major human pathogens.

Main Methods:

• Review of accumulating scientific evidence on immunodominance and subdominance.
• Analysis of studies on subdominant regions in *Plasmodium falciparum*, pathogenic streptococci, dengue virus, and influenza virus.
• Examination of the molecular basis and immune evasion role of subdominance.

Main Results:

• Subdominant protein regions, often surface-exposed and eliciting weak antibody responses, are of significant interest for vaccine development.
• Subdominance can represent an immune evasion strategy, highlighting these regions as critical targets for protective immunity.
• Entire surface-exposed protein domains can be subdominant, as observed across various pathogens studied.

Conclusions:

• Subdominant protein regions represent a largely unexplored but highly promising avenue for novel vaccine development.
• This concept is particularly relevant for bacterial and protozoal pathogens where antibody subdominance is understudied.
• Understanding and targeting subdominant regions could overcome major hurdles in creating vaccines against difficult-to-target pathogens.